0% found this document useful (0 votes)
10 views2 pages

Integrating HIV Care in Home-Based Settings

The project aims to combat the HIV epidemic in sub-Saharan Africa by improving HIV prevention uptake among Adolescent Girls and Young Women (AGYW) and their male partners through new interventions in KwaZulu-Natal. It also introduces the PC4PrEP initiative in the Bronx, NY, to address barriers to PrEP uptake in underserved communities, with a focus on training providers and linking high-risk individuals to care. The project will evaluate the effectiveness of these interventions and their potential for broader application in high HIV incidence areas.

Uploaded by

Lydia Nakiganda
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
10 views2 pages

Integrating HIV Care in Home-Based Settings

The project aims to combat the HIV epidemic in sub-Saharan Africa by improving HIV prevention uptake among Adolescent Girls and Young Women (AGYW) and their male partners through new interventions in KwaZulu-Natal. It also introduces the PC4PrEP initiative in the Bronx, NY, to address barriers to PrEP uptake in underserved communities, with a focus on training providers and linking high-risk individuals to care. The project will evaluate the effectiveness of these interventions and their potential for broader application in high HIV incidence areas.

Uploaded by

Lydia Nakiganda
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Project Title: Integrating HIV care into Home-based Care

Brief Project description

Our overarching goal is to arrest the HIV epidemic and its negative impact on young people in sub
Saharan African (SSA) through improving the uptake, retention and adherence of multi-level
combination HIV prevention by AGYW and male partners. South Africa has an estimated 6.3 million
people living with HIV – the highest in the world. Despite having the largest HIV treatment program
in the world, HIV incidence in Adolescent Girls and Young Women (AGYW aged 15-24) remains
extremely high. Whilst there have been significant innovations in combination HIV prevention, e.g.
universal test and treat (UTT) and Pre-exposure prophylaxis (PrEP), this has far outpaced the ability
to deliver them. To control the HIV epidemic here is an urgent to significantly improve uptake and
retention of HIV prevention by AGYW and male partners, alongside UTT of those testing positive. In
this project we have a unique opportunity to leverage a key time-sensitive events in a poor and rural
hyperendemic area of KwaZulu-Natal: The roll out of eight new youth-focused multi- level HIV
prevention interventions for AGYW and their male partners by PEPFAR’s Determined, Resilient,
Empowered, AIDS free, Mentored, and Safe (DREAMS) program in the context of a state of the art
demographic and health surveillance, where data on individual HIV biomarkers, sexual behaviors,
HIV prevention and ART exposure are linked to public-sector clinical records for HIV and other care.

Although oral pre-exposure prophylaxis (PrEP) has been proven effective in reducing HIV infection in
high-risk men who have sex with men, heterosexually active women and men, and injecting drug
users and approved by the FDA in 2012, uptake has been limited. Significant impediments to PrEP
implementation include: system barriers (lack of a medical "home" and organizational models for
implementing PrEP); provider barriers (difficulty identifying those likely to benefit from PrEP,
inexperience with PrEP, and concerns about adherence and risk compensation); and user barriers
(lack of awareness of PrEP, inability to access providers comfortable with prescribing PrEP, and
concerns about stigma and side effects). Cost is not a barrier in New York State, where PrEP is
covered by many insurance plans, including Medicaid and is provided to the uninsured. Primary Care
for PrEP (PC4PrEP) is a new multilevel structural intervention that will address these diverse barriers
to PrEP uptake in underserved communities in the Bronx, NY, a U.S HIV epicenter. It has 4
components: (1) designate a "home" for PrEP in primary care clinics; (2) train and support primary
care providers (PCPs) to prescribe and manage PrEP, and create provider norms that promote the
value of PrEP; (3) identify high-risk individuals in primary care clinics using a new PrEP Eligibility Tool;
and (4) identify high- risk out-of-care individuals (in collaboration with a community-based
organization (CBO) that conducts outreach and HIV testing in HIV-risk groups) and link them to PCPs
who can provide PrEP. We will conduct a Phase 2 clinic-randomized futility trial of PC4PrEP in 6
Federally Qualified Health Centers (FQHCs) and 6 non- randomized community HIV testing sites to
determine whether PC4PrEP shows promise for increasing the rate of new PrEP prescriptions, assess
its effect on outcomes at each stage of our conceptualization of the "PrEP Cascade," and assess
challenges to PrEP adoption. The Specific Aims are to (1) assess whether PC4PrEP shows promise,
measured as the rate of new PrEP prescriptions per clinic per year; (2) through a phased
implementation of PC4PrEP components, determine the incremental contribution of each
component; (3) evaluate the effects of PC4PrEP on measures of the "PrEP Cascade"; and (4) assess
challenges to PC4PrEP adoption through (a) in-depth interviews with PCPs and support staff about
PC4PrEP; (b) in-depth interviews with selected patient-provider dyads to understand their
communication about PrEP; and (c) a nested longitudinal qualitative study of patients who initiate
PrEP that will include exploration of risk compensation and self-reported adherence augmented by
an objective measure of adherence, dried blood spot assays for tenofovir disphosphate. If shown
effective, PC4PreP will be highly transferable to other primary care clinic/CBO partnerships in high
HIV incidence communities. It is consistent with CDC Guidelines and the Patient Protection and
Affordable Care Act in integrating PrEP into primary care practices and is responsive to the 2014 NYS
Health Department guidelines, which position PrEP as a first-line intervention for high-risk groups.

Common questions

Powered by AI

If the PC4PrEP intervention proves effective, the expected outcomes include a significant increase in the rate of new PrEP prescriptions in the participating clinics, improved measures on the "PrEP Cascade" (such as enhanced awareness and adherence), and better integration of PrEP prescribing into primary care practices. Additionally, it could lead to the potential for scalability and transferability of the intervention to other high-incidence communities. This aligns with CDC guidelines and could be widely adopted by primary care clinic/community-based organization partnerships .

Community-based organizations play a crucial role in the PC4PrEP intervention by collaborating to identify high-risk out-of-care individuals who might benefit from PrEP. These organizations conduct outreach and HIV testing among risk groups and help link identified individuals to primary care providers who can prescribe PrEP, thus reducing user and access barriers to PrEP uptake .

In the rural areas of KwaZulu-Natal, the project leverages the roll-out of eight youth-focused multi-level HIV prevention interventions by PEPFAR’s DREAMS program. These interventions address the high HIV incidence among Adolescent Girls and Young Women and their male partners by coupling state-of-the-art demographic and health surveillance with new approaches like universal test and treat (UTT) and Pre-exposure prophylaxis (PrEP) to improve uptake, retention, and adherence to HIV prevention methods .

The specific aims of the PC4PrEP Phase 2 clinic-randomized futility trial are to: (1) assess whether PC4PrEP shows promise by measuring the rate of new PrEP prescriptions per clinic per year, (2) determine the incremental contribution of each PC4PrEP component through phased implementation, (3) evaluate the effects of PC4PrEP on the "PrEP Cascade," and (4) assess challenges to PC4PrEP adoption through in-depth interviews and a nested longitudinal qualitative study of patients who initiate PrEP .

PC4PrEP plans to address barriers to PrEP uptake through a multilevel structural intervention consisting of four components: (1) designating a "home" for PrEP in primary care clinics, (2) training and supporting primary care providers to prescribe and manage PrEP while promoting provider norms that value PrEP, (3) identifying high-risk individuals in clinics using a new PrEP Eligibility Tool, and (4) collaborating with community-based organizations to identify out-of-care high-risk individuals and link them to primary care providers who can provide PrEP .

The document identifies several barriers to PrEP uptake in high-risk populations, which include system barriers such as the lack of a medical "home" and organizational models for implementing PrEP; provider barriers like difficulty in identifying those who might benefit from PrEP, provider inexperience with PrEP, and concerns about adherence and risk compensation; and user barriers such as a lack of awareness of PrEP, inability to access providers comfortable with prescribing PrEP, and concerns about stigma and side effects .

The PC4PrEP intervention aligns with the CDC Guidelines by positioning PrEP as a first-line intervention for high-risk groups, aiming to integrate PrEP into primary care practices. It is also consistent with the Patient Protection and Affordable Care Act's objectives by enhancing care accessibility and reducing system barriers. This alignment supports a broader public health strategy to reduce HIV incidence rates through improved PrEP uptake in communities with high HIV incidence .

The "PrEP Cascade" is a conceptual framework used to evaluate interventions by measuring the effects of interventions at different stages of the PrEP uptake and adherence process. In the context of PC4PrEP, the trial evaluates how the implementation impacts the cascade stages such as awareness, access, prescription uptake, adherence, and retention among the target high-risk groups. By examining these stages, the intervention's effectiveness in increasing PrEP uptake and adherence can be assessed .

Lessons from the PC4PrEP implementation that could be applicable to similar projects in sub-Saharan Africa include the importance of creating a dedicated 'home' for PrEP within primary care settings, enhancing provider training for PrEP management, and developing partnerships with community-based organizations for outreach and education. Additionally, employing tools to identify high-risk individuals and aiming for a community-centered approach could address systemic and user barriers effectively. Adaptations might need to be made considering the differing healthcare infrastructure and socio-cultural contexts present in sub-Saharan Africa .

The document highlights several systemic challenges to PrEP implementation, including the lack of a medical "home" or centralized organizational models for PrEP provision. Additionally, there are barriers related to insufficient training and experience among healthcare providers to adequately prescribe and manage PrEP. Organizational resistance to adopting PrEP as a standard prevention method might also impede its effective implementation despite innovations such as universal test and treat (UTT).

You might also like